Innovative Cell Therapy, Omisirge, Receives FDA Approval to Reduce Infection Risk in Blood Cancer Treatments
The FDA has approved Omisirge (omidubicel-onlv), a modified allogeneic cord blood-based cell therapy designed to speed up the recovery of neutrophils and reduce infection risk. Omisirge is intended for use in adults and pediatric patients aged 12 and older with blood cancers who are undergoing umbilical cord blood transplantation after a myeloablative conditioning regimen. Blood […]
California Judge Sides with Stem Cell Clinic Against the FDA
The Honorable Jesus Bernal (federal judge in Riverside), has issued his judgement in the United States of America Versus The California Stem Cell Treatment Center. Judge Bernal’s ruling has declared that the stem cells from your own fat are not a drug and the FDA was functioning outside its jurisdiction. Judge Bernal accepted that The […]
Escend Pharmaceuticals, Inc., Receives IND Clearance from the FDA for ES-3000 Phase I Study in Relapsed or Refractory Acute Myeloid Leukemia (AML)
MENLO PARK, Calif., July 15, 2022 /PRNewswire/ — Escend Pharmaceuticals, Inc., a privately held company focused on the development of small molecule therapeutics for oncology orphan diseases, announced today that the United States Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for its lead drug candidate, ES-3000 for a Phase I […]
Stem cells helping patients with Parkinson’s Disease
News segment from Houston’s KPRC talking about the first FDA approved stem cell trial that is happening to help patient’s dealing with Parkinson’s Disease. Video Transcript: More than 10 million people worldwide are living with Parkinson’s and 60,000 are in the U.S.. It’s a chronic progressive disease, which means it gets worse over time. But […]
How Regenerative Medicine & Stem Cell Therapy Impacts Aging
Lance Hitchings has an excellent YouTube channel where he shares everything he has learned on his quest to turn back the hands of time when it comes to aging. In the following video, Lance gives an update on what regenerative medicine and stem cell therapies are currently doing in the field of aging. Video Transcript: […]
Vitti Labs Announces FDA Approval of Phase II IND Clinical Trial of Combination Mesenchymal Stem Cell and Exosome Treatment of Pulmonary Fibrosis Secondary to Novel Corona Virus Infection (COVID-19)
LIBERTY, Mo., May 2, 2022 /PRNewswire/ — Vitti Labs, an AATB Accredited Tissue Bank focused on life Science Research, development, and manufacturing, announced today that the U.S. Food and Drug Administration (FDA) has approved their Investigational New Drug Application (IND) to move forward with Phase II Outpatient Clinical Trial using a combination of Umbilical Cord […]